Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies

por Norris, Stephen, Ramael, Steven, Ikushima, Ippei, Haazen, Wouter, Harada, Akiko, Moschetti, Viktoria, Imazu, Susumu, Reilly, Paul A., Lang, Benjamin, Stangier, Joachim, Glund, Stephan
Publicado 2017

The Impact of “Omic” and Imaging Technologies on Assessing the Host Immune Response to Biodefence Agents

por Tree, Julia A., Flick-Smith, Helen, Elmore, Michael J., Rowland, Caroline A.
Publicado 2014

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review

por Brauer, Ruth, Douglas, Ian, Smeeth, Liam
Publicado 2011

Increased prescription rate of anti‐infective agents after diagnosis of myelodysplastic syndromes

por Rozema, Johanne, Hoogendoorn, Mels, Potma, Iris, ten Seldam, Inge, Veeger, Nic J. G. M., Kibbelaar, Robby E., van de Loosdrecht, Arjan A., van Roon, Eric N.
Publicado 2022

Oral antimicrobial agents in patients with short bowel syndrome: worth a try!

por Korzilius, Julia W, Gompelman, Michelle, Wezendonk, Guus T J, Jager, Nynke G L, Rovers, Chantal P, Brüggemann, Roger J M, Wanten, Geert J A
Publicado 2023

Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models

por Robertson, Gregory T., Scherman, Michael S., Bruhn, David F., Liu, Jiuyu, Hastings, Courtney, McNeil, Michael R., Butler, Michelle M., Bowlin, Terry L., Lee, Robin B., Lee, Richard E., Lenaerts, Anne J.
Publicado 2017

nosoi: A stochastic agent‐based transmission chain simulation framework in r

por Lequime, Sebastian, Bastide, Paul, Dellicour, Simon, Lemey, Philippe, Baele, Guy
Publicado 2020

Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma

por Sasamura, H, Takahashi, A, Miyao, N, Yanase, M, Masumori, N, Kitamura, H, Itoh, N, Tsukamoto, T
Publicado 2002

Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guide...

por Banerjee, Debasish, Winocour, Peter, Chowdhury, Tahseen A., De, Parijat, Wahba, Mona, Montero, Rosa, Fogarty, Damian, Frankel, Andrew, Goldet, Gabrielle, Karalliedde, Janaka, Mark, Patrick B., Patel, Dipesh, Pokrajac, Ana, Sharif, Adnan, Zac-Varghese, Sagen, Bain, Stephen, Dasgupta, Indranil
Publicado 2022

Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single‐agent ibrutinib

por Jones, Jeffrey A., Hillmen, Peter, Coutre, Steven, Tam, Constantine, Furman, Richard R., Barr, Paul M., Schuster, Stephen J., Kipps, Thomas J., Flinn, Ian W., Jaeger, Ulrich, Burger, Jan A., Cheng, Mei, Ninomoto, Joi, James, Danelle F., Byrd, John C., O'Brien, Susan M.
Publicado 2017

Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study

por Marchesini, Gessica, Nadali, Gianpaolo, Facchinelli, Davide, Candoni, Anna, Cattaneo, Chiara, Laurenti, Luca, Fanci, Rosa, Farina, Francesca, Lessi, Federica, Visentin, Andrea, Marchesi, Francesco, Prezioso, Lucia, Spolzino, Angelica, Tisi, Maria Chiara, Trastulli, Fabio, Picardi, Marika, Verga, Luisa, Dargenio, Michelina, Busca, Alessandro, Pagano, Livio
Publicado 2020

A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides

por Peric, Mihaela, Pešić, Dijana, Alihodžić, Sulejman, Fajdetić, Andrea, Herreros, Esperanza, Gamo, Francisco Javier, Angulo‐Barturen, Iñigo, Jiménez‐Díaz, María Belén, Ferrer‐Bazaga, Santiago, Martínez, María S., Gargallo‐Viola, Domingo, Mathis, Amanda, Kessler, Albane, Banjanac, Mihailo, Padovan, Jasna, Bencetić Mihaljević, Vlatka, Munic Kos, Vesna, Bukvić, Mirjana, Eraković Haber, Vesna, Spaventi, Radan
Publicado 2020

Disease-modifying agents in osteoarthritis: where are we now and what does the future hold?

por Makaram, Navnit S., Simpson, A. H. R. W.
Publicado 2023

Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis

por Doeleman, Martijn J H, van Maarseveen, Erik M, Swart, Joost F
Publicado 2019

Pharmacokinetic/pharmacodynamic modeling and simulation of dotinurad, a novel uricosuric agent, in healthy volunteers

por Motoki, Keisuke, Igarashi, Takako, Omura, Koichi, Nakatani, Hiroshi, Iwanaga, Takashi, Tamai, Ikumi, Ohashi, Tetsuo
Publicado 2019

P22 Youth as agents of change in raising AMR awareness in the community in Dodoma region

por Venant, Erick, Stanley, Baritazar K., Mosha, Michael J., Mushi, DorineGrace J., Mwingira, Israel, Harrison, Roger, Wiedenmayer, Karin, Ombaka, Eva
Publicado 2022

The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment

por Lumbers, Eugenie R., Head, Richard, Smith, Gary R., Delforce, Sarah J., Jarrott, Bevyn, H. Martin, Jennifer, Pringle, Kirsty G.
Publicado 2022

An Overview of Cleaning Agents’ Health Hazards and Occupational Injuries and Diseases Attributed to Them in Sweden

por Kathare, Maitreyi, Julander, Anneli, Erfani, Behnaz, Schenk, Linda
Publicado 2022

Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death

por Aft, R L, Zhang, F W, Gius, D
Publicado 2002

Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns: results from the British Society for Rheumatology...

por Derakhshan, Mohammad H, Dean, Linda, Jones, Gareth T, Siebert, Stefan, Gaffney, Karl
Publicado 2020